Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis
Maurits C. F. J. de Rotte(Erasmus MC), Róbert de Jonge(Mission Therapeutics (United Kingdom))
Cited by 58
Related Papers
Clinical features and prognostic factors in Covid-19: A prospective cohort study
|EBioMedicine|2021|137
Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection
|EBioMedicine|2023|38
Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial
|Respiratory Research|2022|18
Association between dexamethasone treatment and the host response in COVID-19 patients admitted to the general ward
|Respiratory Research|2022|9
Endothelial Permeability and the Angiopoietin/Tie2 System Following Mild and Severe COVID-19
|Artery Research|2023|4